These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 21314871

  • 1. Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
    Gaynor P, McCarberg B, Zheng W, Shoemaker S, Duenas H.
    Int J Clin Pract; 2011 Mar; 65(3):341-9. PubMed ID: 21314871
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG, Pritchett YL, Desaiah D, Raskin J.
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [Abstract] [Full Text] [Related]

  • 3. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA, Hall JA, Risser RC, Gonzales JS.
    Pain Pract; 2009 Nov; 9(5):354-62. PubMed ID: 19500272
    [Abstract] [Full Text] [Related]

  • 4. Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.
    Crucitti A, Zhang Q, Nilsson M, Brecht S, Yang CR, Wernicke J.
    Curr Med Res Opin; 2010 Nov; 26(11):2579-88. PubMed ID: 20874076
    [Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.
    Hudson JI, Wohlreich MM, Kajdasz DK, Mallinckrodt CH, Watkin JG, Martynov OV.
    Hum Psychopharmacol; 2005 Jul; 20(5):327-41. PubMed ID: 15912562
    [Abstract] [Full Text] [Related]

  • 6. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 7. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, Chappell AS.
    Clin J Pain; 2009 Dec; 25(6):461-8. PubMed ID: 19542792
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 10. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Sep; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
    Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS.
    Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
    [Abstract] [Full Text] [Related]

  • 13. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA, Hall J, Meyers AL, Gonzales J, Mallinckrodt C.
    J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
    [Abstract] [Full Text] [Related]

  • 16. Pain response profile of patients with fibromyalgia treated with duloxetine.
    Bradley LA, Wohlreich MM, Wang F, Gaynor PJ, Robinson MJ, D'Souza DN, Mease PJ.
    Clin J Pain; 2010 Dec; 26(6):498-504. PubMed ID: 20551724
    [Abstract] [Full Text] [Related]

  • 17. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
    Skljarevski V, Desaiah D, Zhang Q, Chappell AS, Detke MJ, Gross JL, Ziegler D.
    Diabetes Metab Res Rev; 2009 Oct; 25(7):623-31. PubMed ID: 19637208
    [Abstract] [Full Text] [Related]

  • 18. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
    Chappell AS, Littlejohn G, Kajdasz DK, Scheinberg M, D'Souza DN, Moldofsky H.
    Clin J Pain; 2009 Jun; 25(5):365-75. PubMed ID: 19454869
    [Abstract] [Full Text] [Related]

  • 19. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P, Shu L, Xu X, Wang CY, Lee MS, Liu CY, Hong JP, Ruschel S, Raskin J, Colman SA, Harrison GA.
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.